New England Biolabs (United States)
New England Biolabs produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2021. Read More.
Open Access Percentage
76%
Total
Publications
1K
Total Open
Publications
792
Total
Citations
46K
Open Access
Percentage
76%
Total
Publications
1K
Total Open
Publications
792
Total
Citations
46K
Breakdown
Publisher Open
9%
Both
52%
Other Platform Open
15%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 53%
340
Hybrid 29%
184
No Guarantees 18%
114
Other Platform Open
Domain 90%
631
Institution 24%
169
Public 22%
153
Preprint 10%
72
Other Internet 8%
56
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 628 |
Europe PMC | Domain | 550 |
Semantic Scholar | Public | 146 |
bioRxiv | Preprint | 58 |
DOI | Other Internet | 30 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 22 |
University of Sussex - Sussex Research Online | Institution | 19 |
Figshare | Public | 15 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 13 |
CiteSeer X | Other Internet | 12 |